Apexigen, Inc.
APGN · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $13 | $15 | $13 |
| Short-Term Investments | $0 | $0 | $2 | $8 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $3 | $4 |
| Total Curr. Assets | $13 | $17 | $21 | $25 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $2 |
| Total NC Assets | $0 | $1 | $2 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13 | $18 | $23 | $28 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $5 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $7 | $6 | $6 | $5 |
| Other Curr. Liab. | $5 | $5 | $5 | $8 |
| Total Curr. Liab. | $15 | $14 | $16 | $17 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15 | $14 | $16 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$189 | -$183 | -$177 | -$170 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $187 | $186 | $183 | $181 |
| Total Equity | -$2 | $3 | $6 | $10 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13 | $18 | $23 | $28 |
| Net Debt | -$9 | -$13 | -$15 | -$12 |